Literature DB >> 12589050

Reorganization of actin cytoskeleton by the phosphoinositide metabolite glycerophosphoinositol 4-phosphate.

Raffaella Mancini1, Enza Piccolo, Stefania Mariggio', Beatrice Maria Filippi, Cristiano Iurisci, Paolo Pertile, Christopher P Berrie, Daniela Corda.   

Abstract

Glycerophosphoinositol 4-phosphate (GroPIns-4P) is a biologically active, water-soluble phospholipase A metabolite derived from phosphatidylinositol 4-phosphate, whose cellular concentrations have been reported to increase in Ras-transformed cells. It is therefore important to understand its biological activities. Herein, we have examined whether GroPIns-4P can regulate the organization of the actin cytoskeleton, because this could be a Ras-related function involved in cell motility and metastatic invasion. We find that in serum-starved Swiss 3T3 cells, exogenously added GroPIns-4P rapidly and potently induces the formation of membrane ruffles, and, later, the formation of stress fibers. These actin structures can be regulated by the small GTPases Cdc42, Rac, and Rho. To analyze the mechanism of action of GroPIns-4P, we selectively inactivated each of these GTPases. GroPIns-4P requires active Rac and Rho, but not Cdc42, for ruffle and stress fiber formation, respectively. Moreover, GroPIns-4P induces a rapid translocation of the green fluorescent protein-tagged Rac into ruffles, and increases the fraction of GTP-bound Rac, in intact cells. The activation of Rac by GroPIns-4P was near maximal and long-lasting. Interestingly, this feature seems to be critical in the induction of actin ruffles by GroPIns-4P.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12589050      PMCID: PMC149988          DOI: 10.1091/mbc.e02-04-0179

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  47 in total

Review 1.  PIP2 and PIP3: complex roles at the cell surface.

Authors:  M P Czech
Journal:  Cell       Date:  2000-03-17       Impact factor: 41.582

Review 2.  Rho GTPases and their effector proteins.

Authors:  A L Bishop; A Hall
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

Review 3.  The synthesis and cellular roles of phosphatidylinositol 4,5-bisphosphate.

Authors:  A Toker
Journal:  Curr Opin Cell Biol       Date:  1998-04       Impact factor: 8.382

4.  Membrane transport and in vitro metabolism of the Ras cascade messenger, glycerophosphoinositol 4-phosphate.

Authors:  C P Berrie; C Iurisci; D Corda
Journal:  Eur J Biochem       Date:  1999-12

Review 5.  Signal-dependent membrane targeting by pleckstrin homology (PH) domains.

Authors:  M A Lemmon; K M Ferguson
Journal:  Biochem J       Date:  2000-08-15       Impact factor: 3.857

6.  Hepatoma cell migration through a mesothelial cell monolayer is inhibited by cyclic AMP-elevating agents via a Rho-dependent pathway.

Authors:  M Mukai; H Nakamura; M Tatsuta; T Iwasaki; A Togawa; F Imamura; H Akedo
Journal:  FEBS Lett       Date:  2000-11-03       Impact factor: 4.124

Review 7.  The actin cytoskeleton and plasma membrane connection: PtdIns(4,5)P(2) influences cytoskeletal protein activity at the plasma membrane.

Authors:  A S Sechi; J Wehland
Journal:  J Cell Sci       Date:  2000-11       Impact factor: 5.285

Review 8.  FYVE-finger proteins--effectors of an inositol lipid.

Authors:  H Stenmark; R Aasland
Journal:  J Cell Sci       Date:  1999-12       Impact factor: 5.285

9.  RhoA function in lamellae formation and migration is regulated by the alpha6beta4 integrin and cAMP metabolism.

Authors:  K L O'Connor; B K Nguyen; A M Mercurio
Journal:  J Cell Biol       Date:  2000-01-24       Impact factor: 10.539

10.  Differential localization of Rho GTPases in live cells: regulation by hypervariable regions and RhoGDI binding.

Authors:  D Michaelson; J Silletti; G Murphy; P D'Eustachio; M Rush; M R Philips
Journal:  J Cell Biol       Date:  2001-01-08       Impact factor: 10.539

View more
  10 in total

Review 1.  The glycerophosphoinositols: cellular metabolism and biological functions.

Authors:  Daniela Corda; Pasquale Zizza; Alessia Varone; Beatrice Maria Filippi; Stefania Mariggiò
Journal:  Cell Mol Life Sci       Date:  2009-08-09       Impact factor: 9.261

2.  A novel glycerophosphodiester phosphodiesterase, GDE5, controls skeletal muscle development via a non-enzymatic mechanism.

Authors:  Yuri Okazaki; Noriyasu Ohshima; Ikumi Yoshizawa; Yasutomi Kamei; Stefania Mariggiò; Keiko Okamoto; Masahiro Maeda; Yoshihito Nogusa; Yuichiro Fujioka; Takashi Izumi; Yoshihiro Ogawa; Yoshitsugu Shiro; Masanobu Wada; Norihisa Kato; Daniela Corda; Noriyuki Yanaka
Journal:  J Biol Chem       Date:  2010-06-24       Impact factor: 5.157

3.  The natural phosphoinositide derivative glycerophosphoinositol inhibits the lipopolysaccharide-induced inflammatory and thrombotic responses.

Authors:  Mariangela Vessichelli; Stefania Mariggiò; Alessia Varone; Pasquale Zizza; Angelomaria Di Santo; Concetta Amore; Giuseppe Dell'Elba; Adele Cutignano; Angelo Fontana; Carmela Cacciapuoti; Gaetano Di Costanzo; Mariastella Zannini; Tiziana de Cristofaro; Virgilio Evangelista; Daniela Corda
Journal:  J Biol Chem       Date:  2017-06-09       Impact factor: 5.157

4.  The developmentally regulated osteoblast phosphodiesterase GDE3 is glycerophosphoinositol-specific and modulates cell growth.

Authors:  Daniela Corda; Takahiro Kudo; Pasquale Zizza; Cristiano Iurisci; Eri Kawai; Norihisa Kato; Noriyuki Yanaka; Stefania Mariggiò
Journal:  J Biol Chem       Date:  2009-07-13       Impact factor: 5.157

5.  Faciogenital dysplasia protein (FGD1) regulates export of cargo proteins from the golgi complex via Cdc42 activation.

Authors:  Mikhail V Egorov; Mariagrazia Capestrano; Olesya A Vorontsova; Alessio Di Pentima; Anastasia V Egorova; Stefania Mariggiò; M Inmaculada Ayala; Stefano Tetè; Jerome L Gorski; Alberto Luini; Roberto Buccione; Roman S Polishchuk
Journal:  Mol Biol Cell       Date:  2009-03-04       Impact factor: 4.138

6.  PKC-alpha inhibitor MT477 slows tumor growth with minimal toxicity in in vivo model of non-Ras-mutated cancer via induction of apoptosis.

Authors:  Piotr Jasinski; Pawel Zwolak; Kaoru Terai; Daniel Borja-Cacho; Arkadiusz Z Dudek
Journal:  Invest New Drugs       Date:  2009-10-01       Impact factor: 3.850

7.  The phosphatase Shp1 interacts with and dephosphorylates cortactin to inhibit invadopodia function.

Authors:  Alessia Varone; Chiara Amoruso; Marcello Monti; Manpreet Patheja; Adelaide Greco; Luigi Auletta; Antonella Zannetti; Daniela Corda
Journal:  Cell Commun Signal       Date:  2021-06-04       Impact factor: 5.712

8.  The glycerophosphoinositols: from lipid metabolites to modulators of T-cell signaling.

Authors:  Laura Patrussi; Stefania Mariggiò; Daniela Corda; Cosima T Baldari
Journal:  Front Immunol       Date:  2013-07-29       Impact factor: 7.561

9.  Peptide-guided targeting of GPR55 for anti-cancer therapy.

Authors:  Maria Mangini; Enrico Iaccino; Maria Giovanna Mosca; Selena Mimmi; Rosa D'Angelo; Ileana Quinto; Giuseppe Scala; Stefania Mariggiò
Journal:  Oncotarget       Date:  2017-01-17

10.  GDE1/MIR16 is a glycerophosphoinositol phosphodiesterase regulated by stimulation of G protein-coupled receptors.

Authors:  Bin Zheng; Christopher P Berrie; Daniela Corda; Marilyn G Farquhar
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-07       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.